Ignite Creation Date:
2024-05-06 @ 1:28 AM
Last Modification Date:
2024-10-26 @ 11:04 AM
Study NCT ID:
NCT01812330
Status:
UNKNOWN
Last Update Posted:
2015-06-24
First Post:
2013-03-14
Brief Title:
Efficacy and Safety Study of Ticagrelor
Sponsor:
General Hospital of Chinese Armed Police Forces
Organization:
General Hospital of Chinese Armed Police Forces
Study Overview
Official Title:
The Effect of Ticagrelor on Acute Coronary Syndrome Patients With Clopidogrel Resistance Undergoing Percutaneous Coronary Intervention
Status:
UNKNOWN
Status Verified Date:
2015-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the efficacy and safety of ticagrelor with clopidogrel
Detailed Description:
180 elective percutaneous coronary intervention patients with clopidogrel resistance were randomized to three groups Group 1received clopidogrel 75mg qd Group 2received clopidogrel 150mg qd Group 3received ticagrelor 90mg bid after PCIPlatelet funtion were tested by flowcytometric vasodilator-stimulated phosphoproteinVASP analysis before PCIand 3days7days and 1 month after PCIrespectivelyThe aim of our study is to compare the efficacy and safety of ticagrelor with clopidogrel
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None